The high costs of the world’s colossally unequal COVID-19 immunization rates.
Articles on Access to medicines
Displaying all articles
The high cost of pharmaceuticals often means only the richest patients get lifesaving medicines. As coronavirus drugs emerge, it will require hard, creative work to ensure they’re available to all.
Canada is investing millions to develop COVID-19 treatments, but there are no safeguards to ensure that those vaccines and medications will be affordable and accessible to the people who need them.
The global cancer burden especially in developing countries is exacerbated by the high cost of treatment.
Holding patents can be a lucrative and powerful position to be in. Here’s a proposal for how nonprofit patent holders can do more for the common good – and live up to their end of the tax break bargain.
Of women who die from cervical cancer, 87% live in poor countries.
Over the next few weeks, the trade minister will be under intense pressure to renege on the government’s commitment to reject anything in the Trans Pacific Partnership that could undermine the PBS.
It’s twice as common as type 1 diabetes. It kills more Australians than HIV. One in every 100 of us lives with hepatitis C, but the disease receives little attention. Worldwide, around 150 million people…
In the next few days, 12 Pacific Rim countries will make critical decisions about what is potentially the most damaging trade agreement for public health ever signed. The Trans Pacific Partnership agreement…
Top contributors
-
Director, WHO Collaborating Centre for Viral Hepatitis, The Peter Doherty Institute for Infection and Immunity
-
Senior Lecturer in Health Economics, Imperial College London
-
Professor of Public Health, La Trobe University
-
Professor, Special Projects, Obstetrics & Gynaecology, University of Cape Town
-
Health Services Researcher, The University of Melbourne
-
PhD candidate, La Trobe University and Unit Head, Nossal Institute for Global Health, The University of Melbourne
-
Associate Professor of Public Policy and Women's Studies, University of Michigan
-
Director, Institute of Cancer Policy, King's College London
-
Associate Professor, Women’s College Hospital and Research Institute, University of Toronto
-
Adjunct professor, Department of Health Policy & Management, George Washington University
-
Professor of Philosophy, Binghamton University, State University of New York
-
Adjunct Professor, Faculty of Law, L’Université d’Ottawa/University of Ottawa
-
Associate Professor and Research Fellow at the Center on Health, Risk, and Society, American University School of International Service
-
Director of the African Cancer Institute, Faculty of Medicine and Health Sciences , Stellenbosch University